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THE THERAPEUTIC EFFECT OF FATTY ACIDS AND
THE ANTIBIOTIC M-11 ON TINEA PEDIS*
GEORGE H. SCHERR, Pa.D.,t ZENO N. KORTH, M.D., JACK REYNOLD, B.S.
AND J. E. GOTHAM, B.S.
This report is part of a series of studies made to determine the efficacy of mix-
tures of fatty acids alone and in combination with various antibiotics in the
treatment of the superficial mycoses. These studies were performed during
1952, 1953, and 1954, using as subjects the children at the St. James Orphanage
in Omaha, the boys at Father Flanagan's Boys Town, and the medical students
at this institution. This selection gave us patients with age spans of 2—14, 11—20,
and 20—35 years, respectively.
A more detailed presentation of all of these studies and their implications will
be made at another time. The purpose of this paper is to present as a preliminary
report the results using Sopronol® (Wyeth Laboratories, Inc.) and a specific
antibiotic isolated from Streptomyces sp. and designated M-11.
Although mycotic infections other than tinea pedis were found and treated,
only patients with tinea pedis are included in this report.
The effectiveness of preparations containing certain fatty acids for the treat-
ment of superficial mycoses has been well established and reported (5, 6, 7, 8, and
others).
In general, antibiotics have not played the successful role in the treatment of
mycotic diseases that they have in bacterial infections. In fact, numerous reports
have attributed to certain antibiotics the role of enhancing the growth of some
fungus pathogens both in vitro and in vivo (1, 3, 4). Accoi lingly, this study was
undertaken only after the very encouraging in vitro activity of M-11 against
numerous pathogenic fungi was demonstrated.
MATERIALS AND METHODS
AU patients were treated with one of three preparations: Sopronol, the anti-
biotic M-11 in the same vehicle base as that used for Sopronol, and the mixture of
the two. The concentration of the M-1 1 where used was .01 %. Thesepreparations
were contained in 2 oz. blue glass bottles with labels printed as nearly identical as
was possible without jeopardizing identification. The identifying code numbers
were printed in small type as lot numbers. To avoid confusion the name of the
patient was written on the label of the bottle assigned to him. The examiners who
graded the progress of the patients were not aware of the key to the code, and the
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investigator who did know the code did not grade the progress of the patients,
except in a few exceptional instances.
The patients were told to dampen lightly the involved areas once a day, in the
morning, immediately prior to putting on the socks, using a pledget of absorbent
cotton wetted with the prescribed solution, or a piece of rag, the fingers, toilet
paper, or any similar material that would suffice to apply the solutions to the
infected areas.
Infections were graded by the examiners as mild, moderate, or severe, as mani-
fest by erythema, vesicle formation, fissures, edema, scaling, pruritus, exudate,
discoloration, pain, and presence of ids. Among other data recorded in the chart
of each patient were histories of allergies and seasonal occurrence: these data
will be evaluated in a subsequent paper.
The criteria of mycotic involvement were clinical appearance, isolation of an
identifiable dermatophyte from involved tissue, and/or the demonstration of
fungal elements in tissue scrapings. The cultures isolated were not unique and
this report need not be burdened with their enumeration.
Patients were examined once every 7 to 10 days. Although periodic conflicts
prevented strict adherence to this schedule for all patients, in general this re-
quirement was followed rather well. The course of the infection following the
institution of therapy was graded as regression (R), no change (NC), improved
(I), or cured (C). Alteration in the regimen of therapy was not made unless a
patient showed regression or no change for at least three weeks, or unless pro-
gression became too severe and immediate change became necessary.
Classification of the course of the infection as cured required an intact skin in
the infected area free of any visible pathology and free of any irritation as deter-
mined by questioning of the patient. In practically all cases it was urged that
patients who had been cured continue to use the prescribed material for at least a
week following their designation as cured, but the "days to cure" indicated in the
following tables represents the period preceding the first examination of the
patient at which time our criteria for cure were fulifiled.
More patients than indicated in the following tables were examined and
treated. Numerous ones were deleted from our compiled data for various reasons,
e.g., failure to comply with directions, lesions ultimately revealed as being non-
mycotic, loss of patient from institution.
RESULTS
Tables 1, 2, and 3 summarize the data for patients at Boys Town, St. James
Orphanage, and the medical school, respectively; table 4 is a compilation of the
total patients from all three institutions.
The mean treatment period as expressed in days, except for patients that were
cured, merely represents the average time that treatment was administered before
the course of the infection was classified as It, NC, or I. Since these treatment
periods were rather arbitrarily designated, because treatment could have been
prolonged for many more additional days without altering the designated course
of some of these infections, they are not as significant as the mean time to cure.
TABLE 1
The therapeutic effectiveness of Sopronol and/or the antibiotic M-11 on tinea pedis among
the residents of Boys Town
M-ll Sopronol Sopronol and M-ii
Severity of Course of
Tnfection Infectionl Mean Mean Meantreatment treatmentNo. patients treatnnt No. patients period No. patients period
edays)2 (days) (days)
Mild R 11 30.8 3 40.7 0 —
NC 6 31.7 5 41.4 2 44.5
I 0 — 0 —. 0 —
C 21 31.4 37 26.2 44 22.4
Moderate... R 3 23.7 0 — 0 —
NC 8 27.5 4 33.7 0
I 6 43.2 4 38.5 5 28.8
C 10 39.0 31 37.8 25 29.0
Severe R 1 10.0 0 — 0
NC 0 — 0 — 0 —I 2 19.5 2 17.0 6 26.8
C 2 38.0 2 54.5 3 34.0
Total R
NC
I
C
15
14
8
33
(21.4%)
(20.0%)
(11.4%)
(47.2%)
34.1 3
9
6
70
(3.4%)
(10.3%)
(6.8%)
(79.5%)
32.2 0
2
11
72
(0.0%)
(2.3%)
(12.9%)
(84.8%)
25.2
1 R—Regression, NC—no change, I—improved, C—cured.
This represents the average time in days for the group indicated during which actual
treatment was maintained before the course of the infection was classified; for the group
designated "C" it represents the average days to cure.
TABLE 2
The therapeutic effectiveness of Sopronol and/or the antibiotic M-11 on tinea pedis among
the residents of St. James Orphanage
Severity of
Infection
Course of
Infection
M-li Sopronol Sopronol and M-l1
No. patients
Mean
treatment
period(days)
No. patients
Mean
treatment
period(days)
No. patients
Mean
treatment
period(days)
Mild
Moderate...
Severe
R
NCI
C
R
NCI
C
R
NC
I
C
1
5
0
3
0
1
1
0
0
2
1
1
21.0
29.8
—
24.0
—
30.0
40.0
—
—
20.5
21.0
16.0
2
0
0
5
0
0
0
4
0
0
0
0
20.0
—
—
20.4
—
—
—
18.0
—
—
—
—
0
1
0
7
0
0
0
3
0
0
0
2
—
32.0
—
22.7
—
—
—
18.7
—
—
—
32.5
Total R
NC
I
C
1 (6.7%)
8 (53.0%)
2 (13.3%)
4 (26.6%)
15
22.0 2 (18.2%)
0 (0.0%)
0 (0.0%)
9 (81.8%)
11
19.3 0 (0.0%)
1 (7.7%)
0 (0.0%)
12 (92.3%)
13
23.3
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TABLE 3
The therapeutic effectiveness of sopronol and/or the antibiotic M-11 on tinea pedis among the
medical students of the Creighton University School of Medicine
Severity of
Infection
Course of
Infection
M-ll Sopronol Sopronol and M-11
No. patients
Mean
treatment
period(days)
No. patients
Mean
treatment
period(days)
No. Patients
Mean
treatment
period(days)
Mild
Moderate...
Severe
R
NC
I
C
R
NC
I
C
R
NC
I
C
1
1
2
2
2
0
2
1
0
2
0
2
14.0
30.0
8.5
22.0
14.5
—
25.5
10.0
—
22.0
—
17.5
0
0
1
2
0
1
1
2
0
0
0
3
—
—
21.0
21.0
—
21.0
21.0
21.0
—
—
—
25.2
0
0
1
3
0
0
0
3
0
0
0
9
—
16.0
15.5
—
—
8.5
—
—
—
18.3
Total R
NC
I
C
3 (20.0%)
3 (20.0%)
4 (26.7%)
5 (33.3%)
15
17.8 0 (0.0%)
1 (10.0%)
2 (20.0%)
7 (70.0%)
10
22.8 0 (0.0%)
0 (0.0%)
1 (6.3%)
15 (93.7%)
16
15.8
TABLE 4
The therapeutic effectiveness of Sopronol and/or the antibiotic M-I1 on tinea pedis (compiled
data from tables 1, , 8)
Course
of
ection
M-11 Sopronol Sopronol and M-11
No. Patients
treat-
inent
period(days)
No. Patients
treat-
ment
penod(days)
No. Patients
treat-
ment
period(days)
All seventies of
infection R
NC
I
C
19 (19.0%)
25 (25.0%)
14 (14.0%)
42 (42.0%)
100
31.0 5 (4.6%)
10 (9.2%)
8 (7.2%)
86 (79.9%)
109
30.1 0 (0.0%)
3 (2.5%)
12 (10.5%)
99 (86.9%)
114
23.5
Total patients un-
proved or cured.... 56.0% 86.2% 97.4%
The Boys Town group, containing the larger numbers of patients, is the most
valid. Note that the mean number of days to cure was essentially the same for
those patients treated with the M-11 (34.1 days) and those treated with the
Sopronol (32.2 days) (table 1). The mean time to cure patients treated with the
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mixture of Sopronol and M-11 is significantly lower (25.2 days) as compared to
the other two groups (P = .02 —
.05). The total number of patients that were
improved or cured with M-1 1, Sopronol, and the mixture of Sopronol and M-1 1
were 58.6%, 86.3 %, and 97.7 %, respectively. The addition of the comparable
data from tables 2 and 3 to the Boys Town results leaves these values essentially
unchanged—56.0 %, 86.2%, and 97.4%, respectively (table 4).
As might be expected, there is an increase in the mean time to cure with an
increase in the severity of the infection and this is generally true for all three
groups of patients.
DISCUSSION
Although there appear to be significant differences in the mean periods to cure
among these patients of varying age groups and environments, this evaluation
must await the inclusion of larger numbers of patients from St. James Orphanage
and the medical school. The salient features of this study for which we feel we
have substantial data are:
The mixture of Sopronol and M-1 1 resulted in a significantly greater number of
improved and cured patients for all seventies of infection than either of these
preparations alone. Comparing the per cent improved for those patients treated
with M-11 (56.0%) to those treated with the Sopronol (86.2%) yields a P value
of <0.001 (by x2); similarly comparing those treated solely with the Sopronol to
the patients treated with the mixture of Sopronol and M-11, yields a P value of
<0.01.
By determining, using the data of table 4, that a value of 94.0% for the summa-
tion of patients improved or cured would be indicative of an additive effect for
the components of the mixture, it is indicated by the observed value of 97.4%
(table 4) that at least an additive and possibly a synergistic activity was observed.
The use of the mixture significantly reduced the average time to cure, where
enough patients were examined to warrant a statistical evaluation. This reduced
period was approximately a week.
In the light of a previous study by the two senior authors (unpublished data)
in which the antibiotic Bacillomycin, which showed in vitro activity comparable
to M-1 1 (2), was similarly studied and found to add nothing to the therapeutic
efficacy of Sopronol (if not actually detracting from it), we feel that these data
are sufficiently convincing to warrant extended clinical trials with, if not the
clinical acceptance of, the mixture of Sopronol and M-11.
SUMMARY
A mixture of Sopronol and the antibiotic designated as M-1 1 was more effective
in reducing the treatment period necessary to effect a cure of tinea pedis than
either preparation alone. This mixture also resulted in a significantly higher pro-
portion of patients in which the infection was improved or cured, to a degree
which indicated at least an additive and possibly a synergistic effect between the
two agents.
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